Showing 1 to 7 of 7 results


ME/CFS: A Debilitating Illness Impacts Millions
Larisa, 30, exemplifies the debilitating effects of ME/CFS, a neurological condition with potentially doubled prevalence post-COVID-19, characterized by extreme fatigue, pain, and cognitive dysfunction, leaving many incapacitated.
ME/CFS: A Debilitating Illness Impacts Millions
Larisa, 30, exemplifies the debilitating effects of ME/CFS, a neurological condition with potentially doubled prevalence post-COVID-19, characterized by extreme fatigue, pain, and cognitive dysfunction, leaving many incapacitated.
Progress
52% Bias Score


ME/CFS: A Debilitating Illness Lacking Effective Treatment
ME/CFS, a neuroimmunological disease affecting an estimated 17 million globally, severely limits sufferers' daily lives, hindering work and socialization. Current research focuses on impaired blood flow and an overactive immune system as potential root causes, lacking effective treatments despite de...
ME/CFS: A Debilitating Illness Lacking Effective Treatment
ME/CFS, a neuroimmunological disease affecting an estimated 17 million globally, severely limits sufferers' daily lives, hindering work and socialization. Current research focuses on impaired blood flow and an overactive immune system as potential root causes, lacking effective treatments despite de...
Progress
56% Bias Score


Long Covid Prevalence Significantly Reduced, but Long-Term Impacts Remain a Concern
Long Covid, persistent symptoms after a Covid-19 infection, initially affected 6-8% but now affects 1-2% of patients, with women and those with pre-existing conditions at higher risk; long-term symptoms such as fatigue and cognitive impairment can lead to severe disability and require extensive long...
Long Covid Prevalence Significantly Reduced, but Long-Term Impacts Remain a Concern
Long Covid, persistent symptoms after a Covid-19 infection, initially affected 6-8% but now affects 1-2% of patients, with women and those with pre-existing conditions at higher risk; long-term symptoms such as fatigue and cognitive impairment can lead to severe disability and require extensive long...
Progress
52% Bias Score


Body Mapping Improves Communication for Long Covid and ME/CFS Patients
Oxford University researchers are using "body mapping" to help long Covid and ME/CFS patients communicate their experiences, addressing the challenge of subjective symptoms and lack of objective markers; the visual representations of physical, cognitive, and emotional impacts foster better understan...
Body Mapping Improves Communication for Long Covid and ME/CFS Patients
Oxford University researchers are using "body mapping" to help long Covid and ME/CFS patients communicate their experiences, addressing the challenge of subjective symptoms and lack of objective markers; the visual representations of physical, cognitive, and emotional impacts foster better understan...
Progress
40% Bias Score

Wildlife Trade Implicated as Key Factor in SARS-CoV-1 and SARS-CoV-2 Outbreaks
Genetic analysis strongly suggests that both SARS-CoV-1 and SARS-CoV-2 reached their outbreak locations via the wildlife trade, not solely through natural bat-to-bat transmission, highlighting a crucial role for wildlife trade in pandemic origins.

Wildlife Trade Implicated as Key Factor in SARS-CoV-1 and SARS-CoV-2 Outbreaks
Genetic analysis strongly suggests that both SARS-CoV-1 and SARS-CoV-2 reached their outbreak locations via the wildlife trade, not solely through natural bat-to-bat transmission, highlighting a crucial role for wildlife trade in pandemic origins.
Progress
48% Bias Score

ME/CFS: Debilitating Fatigue and the Search for Effective Treatments
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a neuroimmunological disease affecting 17 million globally, marked by debilitating fatigue, pain, and impaired blood circulation, often triggered by prior infection; effective treatments remain elusive due to low research investment.

ME/CFS: Debilitating Fatigue and the Search for Effective Treatments
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a neuroimmunological disease affecting 17 million globally, marked by debilitating fatigue, pain, and impaired blood circulation, often triggered by prior infection; effective treatments remain elusive due to low research investment.
Progress
56% Bias Score

Long COVID Risk Higher in Women; SARS-CoV-2 Link to ME/CFS Found
Two studies using data from the NIH's RECOVER initiative found women have a 31% higher risk of long COVID than men, particularly those aged 40-54 and 55+, and that 4.5% of those infected with SARS-CoV-2 developed ME/CFS, versus 0.6% of uninfected individuals.

Long COVID Risk Higher in Women; SARS-CoV-2 Link to ME/CFS Found
Two studies using data from the NIH's RECOVER initiative found women have a 31% higher risk of long COVID than men, particularly those aged 40-54 and 55+, and that 4.5% of those infected with SARS-CoV-2 developed ME/CFS, versus 0.6% of uninfected individuals.
Progress
28% Bias Score
Showing 1 to 7 of 7 results